Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LIX1 and RIOK2 antisense RNA 1 (LIX1-AS1) is a long non-coding RNA (lncRNA) located on human chromosome 5q15, spanning the region 5:97089075-97439742. As an antisense RNA, LIX1-AS1 is classified among regulatory RNAs that can modulate gene expression through various mechanisms including chromatin modification, regulation of RNA stability, and transcriptional interference. These long non-coding antisense RNAs can influence their associated sense genes by different methods such as direct stabilization of mRNAs, alteration of methylation states in promoter regions, or acting as scaffolds for chromatin-modifying proteins. However, there is currently no direct evidence in the provided search results that LIX1-AS1 itself is a drug target or receptor, nor are there specific drugs, biomarkers, or notable safety concerns reported for this lncRNA. For practical purposes, LIX1-AS1 is best categorized as a non-protein-coding regulatory RNA with potential biological importance in gene regulation, but without sufficient information for clinical targeting or disease associations at this time.
Not applicable (no drugs directly targeting LIX1-AS1 identified).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LIX1 and RIOK2 antisense RNA 1 (LIX1-AS1).